10 | Sphingosine-1-Phosphate ReceptorsIBA
12/2023
-
09/2003 |
6 | sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2018
-
08/2003 |
6 | rho-Associated KinasesIBA
10/2012
-
07/2002 |
5 | sphingosine kinaseIBA
12/2023
-
02/2010 |
5 | SphingosineIBA
12/2023
-
05/2008 |
4 | LysophospholipidsIBA
01/2018
-
06/2002 |
4 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2014
-
03/2009 |
4 | lysophosphatidic acidIBA
01/2013
-
04/2003 |
3 | Proteins (Proteins, Gene)FDA Link
01/2022
-
05/2010 |
3 | LipidsIBA
12/2019
-
01/2009 |
3 | Matrix Metalloproteinase 14 (MT1-MMP)IBA
01/2014
-
10/2009 |
3 | Thromboplastin (Tissue Factor)IBA
01/2014
-
07/2002 |
3 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2010
-
08/2003 |
3 | LigandsIBA
05/2007
-
08/2003 |
2 | Bleomycin (Blenoxane)FDA LinkGeneric
01/2024
-
01/2018 |
2 | CollagenIBA
01/2024
-
01/2013 |
2 | FibrinIBA
01/2020
-
10/2017 |
2 | CholesterolIBA
12/2019
-
11/2010 |
2 | SphingolipidsIBA
12/2019
-
11/2010 |
2 | Interleukin-6 (Interleukin 6)IBA
01/2019
-
01/2017 |
2 | Angiotensin IIIBA
01/2017
-
10/2012 |
2 | CytokinesIBA
01/2013
-
11/2010 |
2 | LeptinIBA
05/2011
-
01/2007 |
2 | Peptides (Polypeptides)IBA
05/2011
-
01/2007 |
2 | LC 6IBA
05/2011
-
01/2007 |
2 | Parathyroid Hormone-Related ProteinIBA
05/2011
-
01/2007 |
1 | Collagen Type I (Type I Collagen)IBA
01/2024 |
1 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024 |
1 | Discoidin Domain Receptor 2IBA
01/2024 |
1 | EndotoxinsIBA
12/2023 |
1 | Phosphotransferases (Kinase)IBA
12/2023 |
1 | Retinaldehyde (Retinal)IBA
12/2023 |
1 | ClathrinIBA
01/2022 |
1 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2022 |
1 | Transcription Factors (Transcription Factor)IBA
07/2018 |
1 | Interleukin-13IBA
01/2018 |
1 | Amyloid (Amyloid Fibrils)IBA
01/2018 |
1 | 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
12/2017 |
1 | Diethylnitrosamine (N-Nitrosodiethylamine)IBA
12/2017 |
1 | (2E,4E,6E,10E)- 3,7,11,15- tetramethyl- 2,4,6,10,14- hexadecapentaenoic acidIBA
12/2017 |
1 | MetalsIBA
10/2017 |
1 | Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2017 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2017 |
1 | Phosphates (Orthophosphate)IBA
01/2017 |
1 | LipopolysaccharidesIBA
09/2016 |
1 | fluorescein isothiocyanate dextranIBA
09/2016 |
1 | Evans Blue (Blue, Evans)FDA Link
09/2016 |
1 | Selenoprotein PIBA
09/2014 |
1 | Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
11/2013 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2013 |
1 | Fibronectins (Fibronectin)IBA
01/2013 |
1 | Transforming Growth Factors (Transforming Growth Factor)IBA
01/2013 |
1 | CeramidesIBA
12/2012 |
1 | JNK Mitogen-Activated Protein KinasesIBA
12/2012 |
1 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2012 |
1 | salicylhydroxamic acid (SHAM)IBA
10/2012 |
1 | JTE 013IBA
10/2012 |
1 | Verapamil (Calan)FDA LinkGeneric
08/2011 |
1 | Nitroglycerin (Dynamite)FDA LinkGeneric
08/2011 |
1 | Myosin Light Chains (Myosin Essential Light Chain)IBA
08/2011 |
1 | fasudil (AT 877)IBA
08/2011 |
1 | Advanced Glycation End ProductsIBA
06/2011 |
1 | NADPH Oxidases (NAD(P)H oxidase)IBA
06/2011 |